Literature DB >> 6201729

Monoclonal antibody against a cross-reactive idiotypic determinant found on human autoantibodies with anti-I and -i specificities.

S W Evans, T Feizi, R Childs, N R Ling.   

Abstract

A monoclonal antibody has been raised against a cross-reactive idiotypic determinant expressed on human autoantibodies with anti-I and -i specificities. The McAb is directed against a conformational epitope requiring interaction of H- and L-chains for maximal expression. This epitope was strongly expressed on the monoclonal protein of one out of 100 patients with paraproteinaemia and the peripheral blood lymphocytes of one out of 50 cases of B-cell leukaemia. A small amount of the epitope is detectable among immunoglobulins in normal serum.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6201729     DOI: 10.1016/0161-5890(83)90122-0

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  4 in total

1.  Cross-reactive variable-region associated epitopes of human IgG1 lambda paraprotein detected by a monoclonal antibody panel.

Authors:  L C Walker; S Dhut; W M Gregory; J A Habeshaw
Journal:  Immunology       Date:  1987-07       Impact factor: 7.397

2.  Investigation of the idiotypic determinants of IgM monoclonal proteins associated with neuropathy.

Authors:  S W Evans; N A Gregson; S L Leibowitz; N R Ling
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

3.  Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice.

Authors:  Peter Ohlschläger; Wolfram Osen; Kerstin Dell; Stefan Faath; Robert L Garcea; Ingrid Jochmus; Martin Müller; Michael Pawlita; Klaus Schäfer; Peter Sehr; Caroline Staib; Gerd Sutter; Lutz Gissmann
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

4.  Selective expression of a VHIV subfamily of immunoglobulin genes in human CD5+ B lymphocytes from cord blood.

Authors:  R A Mageed; L E MacKenzie; F K Stevenson; B Yuksel; F Shokri; B R Maziak; R Jefferis; P M Lydyard
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.